A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-12-22
DOI
10.3389/fimmu.2017.01884
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015
- (2017) Christopher Troeger et al. LANCET INFECTIOUS DISEASES
- Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe
- (2017) Odile Launay et al. EBioMedicine
- Shigella Vaccine Development: Finding the Path of Least Resistance
- (2016) Wilbur H. Chen et al. Clinical and Vaccine Immunology
- Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study
- (2016) Mark S. Riddle et al. Clinical and Vaccine Immunology
- Quantitative proteomic analysis of Shigella flexneri and Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) reveals highly pure preparations
- (2016) Luana Maggiore et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Haidong Wang et al. LANCET
- Status of vaccine research and development for Shigella
- (2016) Sachin Mani et al. VACCINE
- Multi-epitope Models Explain How Pre-existing Antibodies Affect the Generation of Broadly Protective Responses to Influenza
- (2016) Veronika I. Zarnitsyna et al. PLoS Pathogens
- Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review
- (2016) Vincent Muturi-Kioi et al. PLoS One
- Shift in serotype distribution of Shigella species in China, 2003–2013
- (2015) S. Qiu et al. CLINICAL MICROBIOLOGY AND INFECTION
- The Rising Dominance of Shigella sonnei: An Intercontinental Shift in the Etiology of Bacillary Dysentery
- (2015) Corinne N. Thompson et al. PLoS Neglected Tropical Diseases
- Failure of Syndrome-Based Diarrhea Management Guidelines to DetectShigellaInfections in Kenyan Children
- (2015) P. B. Pavlinac et al. Journal of the Pediatric Infectious Diseases Society
- Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB
- (2015) Christiane Gerke et al. PLoS One
- Shigella Isolates From the Global Enteric Multicenter Study Inform Vaccine Development
- (2014) S. Livio et al. CLINICAL INFECTIOUS DISEASES
- Treatment of drug-resistantShigellainfections
- (2014) Karl C Klontz et al. Expert Review of Anti-Infective Therapy
- Development and assessment of molecular diagnostic tests for 15 enteropathogens causing childhood diarrhoea: a multicentre study
- (2014) Jie Liu et al. LANCET INFECTIOUS DISEASES
- Maternal Antibodies: Clinical Significance, Mechanism of Interference with Immune Responses, and Possible Vaccination Strategies
- (2014) Stefan Niewiesk Frontiers in Immunology
- Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study
- (2013) Karen L Kotloff et al. LANCET
- Recent progress towards development of aShigellavaccine
- (2012) Ana Isabel Camacho et al. Expert Review of Vaccines
- Race-specific WBC and neutrophil count reference intervals
- (2010) E.-M. LIM et al. International Journal of Laboratory Hematology
- CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa
- (2009) Etienne Karita et al. PLoS One
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started